Prostate Cancer
Studies from Texas Tech University Provide New Data on Prostate Cancer
Published in Gene Therapy Weekly, September 29th, 2011
2011 SEP 29 -- New investigation results, "PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NF'B and PPAR," are detailed in a study published in Cytokine. According to the authors of a study from Lubbock, Texas, "Interleukin-8 (IL8/CXCL8) has been described as a key effector in prostate cancer progression and resistance to standard chemotherapeutic drugs. In the present study, we investigated the effect of the natural, angio-inhibitory and anti-tumoral Pigment Epithelium-Derived Factor (PEDF) on the expression of IL8 cytokine by prostate cancer cells."
"Using a cytokine antibody array and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-09-29)
More Articles from Gene Therapy Weekly
- Nanoparticles
Data from University of Aalborg Provide New Insights into Nanoparticles - Ischemia
Data on Ischemia Discussed by Researchers at University of Texas - Lung Cancer
Data on Lung Cancer Detailed by Researchers at University of Molise - Antisense Technology
Findings from Guangdong Pharmaceutical University Provide New Insights into Antisense Technology - Small Interference RNAs (siRNAs)
Findings from Zhejiang University Advance Knowledge in Small Interference RNAs (siRNAs) - Gene Therapy
Hokkaido University Details Research in Gene Therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
